Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,411 INR | +0.18% |
|
+3.80% | +65.20% |
06:40am | Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Epilepsy Drug | MT |
07-11 | Glenmark Pharmaceuticals to Sell 7.84% Stake in Glenmark Life Sciences | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+65.20% | 4.76B | |
+25.40% | 45.35B | |
+38.38% | 24.34B | |
+27.09% | 16.51B | |
+21.19% | 14.6B | |
+71.91% | 14.27B | |
-0.05% | 6.79B | |
-11.63% | 6.57B | |
+15.08% | 5.76B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Epilepsy Drug